Literature DB >> 30121859

Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis.

Silvia Pieralice1, Francesca Vigevano1, Rossella Del Toro1, Nicola Napoli1, Ernesto Maddaloni2.   

Abstract

PURPOSE OF REVIEW: To describe the main pathways involved in the interplay between bone and cardiovascular disease and to highlight the possible impact of physical activity and medical nutrition therapy on the bone-vascular axis. RECENT
FINDINGS: Diabetes increases the risk of both cardiovascular disease and bone fragility fractures, sharing common pathogenic pathways, including OPG/RANK/RANKL, the FGF23/Klotho axis, calciotropic hormones, and circulating osteogenic cells. This may offer new therapeutic targets for future treatment strategies. As lifestyle intervention is the cornerstone of diabetes treatment, there is potential for an impact on the bone-vascular axis. Evidence published suggests the bone-vascular axis encompasses key pathways for cardiovascular disease. This, along with studies showing physical activity plays a crucial role in the prevention of both bone fragility and cardiovascular disease, suggests that lifestyle intervention incorporating exercise and diet may be helpful in managing skeletal health decline in diabetes. Studies investigating the controversial role of high-fiber diet and dietary vitamin D/calcium on bone and cardiovascular health suggest an overall benefit, but further investigations are needed in this regard.

Entities:  

Keywords:  Calcium; Cardiovascular disease; Fiber; Lifestyle; Physical activity; Vitamin D

Mesh:

Substances:

Year:  2018        PMID: 30121859     DOI: 10.1007/s11892-018-1060-y

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  138 in total

Review 1.  Fibroblast growth factor 23 and the bone-vascular axis: lessons learned from animal studies.

Authors:  Giacomo Zoppellaro; Elisabetta Faggin; Massimo Puato; Paolo Pauletto; Marcello Rattazzi
Journal:  Am J Kidney Dis       Date:  2011-11-08       Impact factor: 8.860

2.  Physical activity and circulating endothelial progenitor cells: an intervention study.

Authors:  Francesca Cesari; Francesco Sofi; Anna M Gori; Ilaria Corsani; Andrea Capalbo; Roberto Caporale; Rosanna Abbate; Gian F Gensini; Alessandro Casini
Journal:  Eur J Clin Invest       Date:  2012-03-29       Impact factor: 4.686

Review 3.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

Review 4.  Arterial calcification and bone physiology: role of the bone-vascular axis.

Authors:  Bithika Thompson; Dwight A Towler
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

5.  Fracture risk in diabetic elderly men: the MrOS study.

Authors:  Nicola Napoli; Elsa S Strotmeyer; Kristine E Ensrud; Deborah E Sellmeyer; Douglas C Bauer; Andrew R Hoffman; Thuy-Tien L Dam; Elizabeth Barrett-Connor; Lisa Palermo; Eric S Orwoll; Steven R Cummings; Dennis M Black; Ann V Schwartz
Journal:  Diabetologia       Date:  2014-06-09       Impact factor: 10.122

6.  Characterization of circulating osteoblast lineage cells in humans.

Authors:  Guiti Z Eghbali-Fatourechi; Ulrike I L Mödder; Natthinee Charatcharoenwitthaya; Arunik Sanyal; Anita H Undale; Jackie A Clowes; James E Tarara; Sundeep Khosla
Journal:  Bone       Date:  2007-01-04       Impact factor: 4.398

7.  Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts.

Authors:  Marian L Neuhouser; Sylvia Wassertheil-Smoller; Cynthia Thomson; Aaron Aragaki; Garnet L Anderson; JoAnn E Manson; Ruth E Patterson; Thomas E Rohan; Linda van Horn; James M Shikany; Asha Thomas; Andrea LaCroix; Ross L Prentice
Journal:  Arch Intern Med       Date:  2009-02-09

Review 8.  Understanding the pathology and mechanisms of type I diabetic bone loss.

Authors:  Laura R McCabe
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

9.  Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial.

Authors:  M Bouchonville; R Armamento-Villareal; K Shah; N Napoli; D R Sinacore; C Qualls; D T Villareal
Journal:  Int J Obes (Lond)       Date:  2013-07-04       Impact factor: 5.095

10.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

View more
  4 in total

1.  The role of RANKL and FGF23 in Assessing Bone Turnover in Type 2 Diabetic Patients.

Authors:  G Niță; O Niță; A Gherasim; L I Arhire; A M Herghelegiu; L Mihalache; C Tuchilus; M Graur
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 1.104

Review 2.  Adult-onset autoimmune diabetes.

Authors:  Raffaella Buzzetti; Ernesto Maddaloni; Jason Gaglia; R David Leslie; F Susan Wong; Bernhard O Boehm
Journal:  Nat Rev Dis Primers       Date:  2022-09-22       Impact factor: 65.038

3.  Shuxuetong injection simultaneously ameliorates dexamethasone-driven vascular calcification and osteoporosis.

Authors:  Zhe Xu; Xiaoguang Liu; Yanqing Li; Hongliang Gao; Tao He; Chunlei Zhang; Wei Hao; Xu Teng
Journal:  Exp Ther Med       Date:  2021-01-08       Impact factor: 2.447

4.  Genistein prevents bone loss in type 2 diabetic rats induced by streptozotocin.

Authors:  Rongrong Lu; Zicong Zheng; Yimin Yin; Zhuoqin Jiang
Journal:  Food Nutr Res       Date:  2020-12-09       Impact factor: 3.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.